Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2015
DOI: 10.5935/0103-5053.20150023
|View full text |Cite
|
Sign up to set email alerts
|

Main Degradation Products of Dabigatran Etexilate Evaluated by LC-UV and LC-ESI-MS, Degradation Kinetics andin vitroCytotoxicity Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 1 publication
0
3
1
Order By: Relevance
“…According to the MTT analysis, dabigatran showed toxic effects in all dilutions with the highest cytotoxicity. In a cytotoxicity study, although the study design and test concentrations of dabigatran were different from our study, no cytotoxic effect was shown with dabigatran and degradation products (24). In a real-life setting and clinical practice, mid-esophageal ulcer was reported in some of the patients using dabigatran, suggesting that dabigatran has a direct caustic effect on capsular formation (25,26).…”
Section: Assessment Of Cell Viabilitycontrasting
confidence: 67%
“…According to the MTT analysis, dabigatran showed toxic effects in all dilutions with the highest cytotoxicity. In a cytotoxicity study, although the study design and test concentrations of dabigatran were different from our study, no cytotoxic effect was shown with dabigatran and degradation products (24). In a real-life setting and clinical practice, mid-esophageal ulcer was reported in some of the patients using dabigatran, suggesting that dabigatran has a direct caustic effect on capsular formation (25,26).…”
Section: Assessment Of Cell Viabilitycontrasting
confidence: 67%
“…Sitagliptin phosphate reference standard (99.5%), vildagliptin reference standard (99.5%), and 3-(trifluoromethyl)-5,6,7,8-tetrahydro -[1, 2, 4] triazolo [4,3-a]pyrazine-HCl (99.3%) (impurity S1) were supplied by Sequoia Research Products (Oxford, UK). O-benzylhydroxylamine hydrochloride (99.0%) (impurity S2), 2-pyrrolidinecarboxamide (98.0%) (impurity V1) and 3-amino-1-adamantanol (96.0%) (impurity V2) were supplied by Sigma-Aldrich (Brazil).…”
Section: Methodsmentioning
confidence: 99%
“…Drug toxicity is one of the main challenges for the pharmaceutical industry and it also contributes to late-stage failures, increased cost, and market withdrawals [1]. Nowadays, besides the toxicity of compounds present in drug formulations, attention is being paid to the presence of impurities [26].…”
Section: Introductionmentioning
confidence: 99%
“…The precision of the method was good as indicated by %RSD values less than 1.0. The proposed method forced degradation study was also carried out, but characterisation of all the DPs and the degradation pathway were not attempted [11].…”
Section: Introductionmentioning
confidence: 99%